Авторлор жөнүндө
Токтогулова Нургуль Асылбековна, к.м.н., доцент, зав. кафедрой терапии №1 специальностей «Педиатрия» и «Стоматология» КРСУ им. Б.Н. Ельцина, Бишкек, Бишкек, Кыргызская Республика
Султаналиева Роза Бакаевна, д.м.н., профессор кафедры терапии №1 специальностей «Педиатрия» и «Стоматология» КРСУ им. Б.Н. Ельцина, Бишкек, Кыргызская Республика
Тухватшин Рустам Романович, д.м.н., профессор, зав. кафедрой патологической физиологии КГМА им. И.К. Ахунбаева, Бишкек, Кыргызская Республика
Toktogulova Nurgul Asylbekovna, Ph.D., Associate Professor, Head of Therapy No. 1 department of the specialties "Pediatrics" and "Dentistry" KRSU named after B.N. Yeltsin, Bishkek, Kyrgyz Republic
Sultanalieva Roza Bakaevna, MD, Professor of the Department of Therapy No. 1 of the specialties "Pediatrics" and "Dentistry" KRSU named after B.N. Yeltsin, Bishkek, Kyrgyz Republic
Tukhvatshin Rustam Romanovich, MD, Professor, Head Department of Pathological Physiology, KSMA named after I.K. Akhunbaeva, Bishkek, Kyrgyz Republic
Токтогулова Нургүл Асылбековна, м.и.к., доцент, Б.Н. Ельцин атындагы КРСУнун «Педиатрия» жана «Стоматология» адистиктеринин No1 терапия кафедрасынын башчысы, Бишкек, Кыргыз Республикасы
Султаналиева Роза Бакаевна, медицина илимдеринин кандидаты, Б.Н. Ельцинатындагы КРСУнун «Педиатрия» жана «Стоматология» адистиктеринин №1 терапия кафедрасынын профессору, Бишкек, Кыргыз Республикасы
Тухватшин Рустам Романович, м.и.д., профессор, И.К. Ахунбаев атындагы КММАнын патологиялык физиология кафедрасынын башчысы, Бишкек, Кыргыз Республикасы
Шилтемелер
1. Fitzpatrick E., Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future//World journal of gastroenterology: WJG. – 2014. – Т. 20. – №. 31. – С. 10851.
2. Younossi Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 //Clinical gastroenterology and hepatology. – 2011. – Т. 9. – №. 6. – С. 524-530. e1.
3. Sattar N., Forrest E., Preiss D. Non-alcoholic fatty liver disease //Bmj. – 2014. – Т. 349.
4. Wei J. L. et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using protonmagnetic resonance spectroscopy //Official journal of the American College of Gastroenterology| ACG. – 2015. – Т. 110. – №.9. – С. 1306-1314.
5. Fan J. G., Kim S. U., Wong V. W. S. New trends on obesity and NAFLD in Asia //Journal of hepatology. – 2017. – Т. 67. – №. 4.– С. 862-873.
6. Nishioji K. et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012 //Journal of gastroenterology. – 2015. – Т. 50. – №. 1. – С. 95-108.
7. Madan K. et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians //World Journal of Gastroenterology: WJG. – 2006. – Т. 12. – №. 21. – С. 3400.
8. Singh D. K. et al. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis //Digestive diseases and sciences. – 2008. – Т. 53. – №. 7. – С. 1967-1976.
9. Marini M. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.– 2008.
10. Consultation W. H. O. E. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies //Lancet (London, England). – 2004. – Т. 363. – №. 9403. – С. 157-163.
11. Song K. et al. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling //Life sciences. – 2020. – Т. 252. – С. 117633.
12. Анисонян А. В. и др. Неалкогольная жировая болезнь печени и сахарный диабет 2-го типа: вопросы диагностики фиброза печени //Терапевтический архив. – 2020. – Т. 92. – №. 8. – С. 73-78.
13. Fukuoka Y. et al. Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients //Journal of diabetes investigation. – 2019. – Т. 10. – №. 2. – С. 322-330.
1. Fitzpatrick E., Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future//World journal of gastroenterology: WJG. – 2014. – Т. 20. – №. 31. – С. 10851.
2. Younossi Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 //Clinical gastroenterology and hepatology. – 2011. – Т. 9. – №. 6. – С. 524-530. e1.
3. Sattar N., Forrest E., Preiss D. Non-alcoholic fatty liver disease //Bmj. – 2014. – Т. 349.
4. Wei J. L. et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using protonmagnetic resonance spectroscopy //Official journal of the American College of Gastroenterology| ACG. – 2015. – Т. 110. – №.9. – С. 1306-1314.
5. Fan J. G., Kim S. U., Wong V. W. S. New trends on obesity and NAFLD in Asia //Journal of hepatology. – 2017. – Т. 67. – №. 4.– С. 862-873.
6. Nishioji K. et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012 //Journal of gastroenterology. – 2015. – Т. 50. – №. 1. – С. 95-108.
7. Madan K. et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians //World Journal of Gastroenterology: WJG. – 2006. – Т. 12. – №. 21. – С. 3400.
8. Singh D. K. et al. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis //Digestive diseases and sciences. – 2008. – Т. 53. – №. 7. – С. 1967-1976.
9. Marini M. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.– 2008.
10. Consultation W. H. O. E. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies //Lancet (London, England). – 2004. – Т. 363. – №. 9403. – С. 157-163.
11. Song K. et al. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling //Life sciences. – 2020. – Т. 252. – С. 117633.
12. Анисонян А. В. и др. Неалкогольная жировая болезнь печени и сахарный диабет 2-го типа: вопросы диагностики фиброза печени //Терапевтический архив. – 2020. – Т. 92. – №. 8. – С. 73-78.
13. Fukuoka Y. et al. Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients //Journal of diabetes investigation. – 2019. – Т. 10. – №. 2. – С. 322-330.
1. Fitzpatrick E., Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future//World journal of gastroenterology: WJG. – 2014. – Т. 20. – №. 31. – С. 10851.
2. Younossi Z. M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 //Clinical gastroenterology and hepatology. – 2011. – Т. 9. – №. 6. – С. 524-530. e1.
3. Sattar N., Forrest E., Preiss D. Non-alcoholic fatty liver disease //Bmj. – 2014. – Т. 349.
4. Wei J. L. et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using protonmagnetic resonance spectroscopy //Official journal of the American College of Gastroenterology| ACG. – 2015. – Т. 110. – №.9. – С. 1306-1314.
5. Fan J. G., Kim S. U., Wong V. W. S. New trends on obesity and NAFLD in Asia //Journal of hepatology. – 2017. – Т. 67. – №. 4.– С. 862-873.
6. Nishioji K. et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012 //Journal of gastroenterology. – 2015. – Т. 50. – №. 1. – С. 95-108.
7. Madan K. et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians //World Journal of Gastroenterology: WJG. – 2006. – Т. 12. – №. 21. – С. 3400.
8. Singh D. K. et al. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis //Digestive diseases and sciences. – 2008. – Т. 53. – №. 7. – С. 1967-1976.
9. Marini M. et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.– 2008.
10. Consultation W. H. O. E. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies //Lancet (London, England). – 2004. – Т. 363. – №. 9403. – С. 157-163.
11. Song K. et al. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling //Life sciences. – 2020. – Т. 252. – С. 117633.
12. Анисонян А. В. и др. Неалкогольная жировая болезнь печени и сахарный диабет 2-го типа: вопросы диагностики фиброза печени //Терапевтический архив. – 2020. – Т. 92. – №. 8. – С. 73-78.
13. Fukuoka Y. et al. Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients //Journal of diabetes investigation. – 2019. – Т. 10. – №. 2. – С. 322-330.